NOVEL SPIRO COMPOUND, AND PHARMACEUTICAL PREPARATION COMPRISING THE SAME
申请人:Kowa Company, Ltd.
公开号:EP2311811A1
公开(公告)日:2011-04-20
It is to provide a novel compound useful for preventing and/or treating diabetes, insulin resistance, diabetes complication, obesity, dyslipidemia, hypertension, fatty liver, or metabolic syndrome.
A spiro compound represented by the following general formula (1) or salt thereof, or their solvate.
NOVEL SPIRO COMPOUND AND MEDICINE COMPRISING THE SAME
申请人:Nakashima Hisashi
公开号:US20100022572A1
公开(公告)日:2010-01-28
It is to provide a novel compound useful for preventing and/or treating diabetes, insulin resistance, diabetes complication, obesity, dyslipidemia, hypertension, fatty liver, or metabolic syndrome.
A spiro compound represented by the following general formula (1) or salt thereof, or their solvate.